Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ThermoDox with standardized RFA in hepatocellular carcinoma
NCT02112656Phase 3Completed
- Sponsor
- Imunon, Inc.
- Start
- Jun 2014
- Primary completion
- Apr 2020
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of ThermoDox in hepatocellular carcinoma (HCC), sponsored by Imunon, Inc.. Started Jun 2014; status: completed.
02
Drugs
ThermoDox
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02112656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112656.